- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01371552
Performance Evaluation of a New Daily Disposable Silicone Hydrogel Lens (TUNGSTEN)
October 2, 2012 updated by: CIBA VISION
Performance Evaluation of a New Daily Disposable Silicone Hydrogel Lens (TUNGSTEN)
The purpose of this study was to compare a new daily disposable, silicone hydrogel contact lens to marketed daily disposable, silicone hydrogel contact lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Part 1 of the study involved bilateral wear of three different types of marketed contact lenses.
Each type of lens was worn for three consecutive days of daily disposable wear.
Participants had been previously identified as symptomatic lens wearers or asymptomatic lens wearers, based upon their responses to a screening questionnaire.
Participants wore each lens type for as long as they were comfortable during the day, but lenses were removed before sleep.
After completion of Part 1, participants began Part 2, which included dispensing of the investigational study lens for up to one week of bilateral wear, with a single follow-up visit at the end of that period.
Study Type
Interventional
Enrollment (Actual)
119
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- University of Waterloo Centre for Contact Lens Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 17 years of age; full legal capacity to volunteer.
- Ocular examination within the last two years
- Correctable to a visual acuity of 20/30 or better (in each eye) with habitual vision correction.
- Currently wearing soft contact lenses.
- Clear corneas; no active ocular disease.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Currently wearing 1-DAY ACUVUE TruEye or Sauflon Clariti 1-DAY contact lenses.
- Monovision.
- Any ocular disease.
- Never worn contact lenses before.
- Corneal refractive surgery.
- Uses topical ocular medicine.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: delefilcon A
Part 1: Delefilcon A contact lenses, followed by filcon II 3 contact lenses and narafilcon A contact lenses (in randomized order).
Each product worn for three consecutive days, with a minimum 1-day washout between each product.
At the conclusion of this wear cycle, the delefilcon A contact lenses were worn in Part 2 for one additional week.
All products worn bilaterally in a daily wear, daily disposable modality.
|
Investigational, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1 and one week in Part 2.
Commercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.
Other Names:
Commercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.
Other Names:
|
Active Comparator: filcon II 3
Part 1: Filcon II 3 contact lenses, followed by narafilcon A contact lenses and delefilcon A contact lenses (in randomized order).
Each product worn for three consecutive days, with a minimum 1-day washout between each product.
At the conclusion of this wear cycle, the delefilcon A contact lenses were worn in Part 2 for one additional week.
All products worn bilaterally in a daily wear, daily disposable modality.
|
Investigational, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1 and one week in Part 2.
Commercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.
Other Names:
Commercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.
Other Names:
|
Active Comparator: narafilcon A
Part 1: Narafilcon A contact lenses, followed by filcon II 3 contact lenses and delefilcon A contact lenses (in randomized order).
Each product worn for three consecutive days, with a minimum 1-day washout between each product.
At the conclusion of this wear cycle, the delefilcon A contact lenses were worn in Part 2 for one additional week.
All products worn bilaterally in a daily wear, daily disposable modality.
|
Investigational, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1 and one week in Part 2.
Commercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.
Other Names:
Commercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Value of Comfort During the Day
Time Frame: Part 1: Day 2 at 4 hours, 8 hours, and 12 hours
|
The participant recorded a number from 0 to 100 in response to the question, "How would you rate the comfort of your lenses over the last hour?" in which 0 = very poor and 100 = excellent.
Comfort was assessed at 4 hours, 8 hours, and 12 hours, and the responses were averaged.
|
Part 1: Day 2 at 4 hours, 8 hours, and 12 hours
|
Mean Overall Comfort Given at End of Wear
Time Frame: Part 1: Day 3
|
The participant recorded a number from 0 to 100 in response to the question, "How would you rate the overall comfort of these lenses?" in which 0 = very poor and 100 = excellent.
The end of wear questionnaire was completed at time of lens removal for that day.
|
Part 1: Day 3
|
Mean Overall Quality of Vision at End of Wear
Time Frame: Part 1: Day 3
|
The participant recorded a number from 0 to 100 in response to the question, "How would you rate the overall quality of vision while wearing these lenses?" in which 0 = very poor and 100 = excellent.
The end of wear questionnaire was completed at time of lens removal for that day.
|
Part 1: Day 3
|
Mean Overall Ease of Handling at End of Wear
Time Frame: Part 1: Day 3
|
The participant recorded a number from 0 to 100 in response to the question, "How would you rate the overall ease of handling these lenses?" in which 0 = very difficult and 100 = very easy.
The end of wear questionnaire was completed at time of lens removal for that day.
|
Part 1: Day 3
|
Percentage of Participants Reporting That Their Eyes Rarely or Never Felt Dry at End of Wear
Time Frame: Part 1: Day 2
|
The participant circled a number from 0 to 4 in response to the question, "Over the entire day while wearing these contact lenses, how often did your eyes feel dry?" in which 0 = never, 1 = rarely, 2 = sometimes, 3 = frequently, 4 = constantly.
The end of wear questionnaire was completed at time of lens removal for that day.
|
Part 1: Day 2
|
Percentage of Participants Preferring Study Lens Either Strongly or Slightly (of Those With a Preference) vs. Their Habitual Lenses at End of Wear
Time Frame: Part 1: Day 3
|
The participant circled a number from 1 to 5 in response to the question, "Overall, which lens do you prefer - the lens you wore today or your regular lenses?" in which 1 = strongly prefer my regular lenses, 2 = prefer my regular lenses, 3 = no preference, 4 = prefer test lens, 5 = strongly prefer test lens.
The end of wear questionnaire was completed at time of lens removal for that day.
|
Part 1: Day 3
|
Lens Wettability
Time Frame: Part 1: Day 1 at Dispense, Day 1 at 8 hours, Day 3 at 8 hours
|
Lens wettability was assessed by the investigator during slit-lamp examination and graded on a 0-4 scale in 0.25 steps, where 0 = excellent and 4 = severely reduced.
|
Part 1: Day 1 at Dispense, Day 1 at 8 hours, Day 3 at 8 hours
|
Percentage of Participants Responding "Yes"
Time Frame: Part 2: Day 7
|
The participant responded to 11 subjective, performance-related statements on a questionnaire by circling 1 = yes, 2 = no, or 3 = don't know.
|
Part 2: Day 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lyndon Jones, PhD FAAO, Centre for Contact Lens Research, School of Optometry, University of Waterloo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Actual)
August 1, 2011
Study Completion (Actual)
August 1, 2011
Study Registration Dates
First Submitted
June 9, 2011
First Submitted That Met QC Criteria
June 9, 2011
First Posted (Estimate)
June 13, 2011
Study Record Updates
Last Update Posted (Estimate)
October 31, 2012
Last Update Submitted That Met QC Criteria
October 2, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-371-C-100 v2
- P/319/08/C (Other Identifier: University of Waterloo)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on delefilcon A contact lens
-
Alcon ResearchCompletedRefractive Error | Astigmatism | Myopia
-
Johnson & Johnson Vision Care, Inc.CompletedVision DisordersUnited States
-
CIBA VISIONAston UniversityCompleted
-
CIBA VISIONCompleted
-
Alcon ResearchCompletedRefractive Error | Myopia
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchAston UniversityCompleted
-
Alcon ResearchCompleted